descendantsDNA, Inc. is pleased to announce a new agreement with Broad Clinical Labs (BCL) to advance human longevity through cutting-edge genomics.
Aspirin Cuts Liver Fat in Preliminary MASLD Trial
Daily low-dose aspirin reduced hepatic fat in patients with noncirrhotic metabolic dysfunction-associated steatotic liver disease (MASLD), a randomized phase II trial showed. Among the 80